DJIA 16,408.54 0.00 0.00%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 0.00 0.00%
market minute promo

Array BioPharma

NASDAQ: ARRY

3.79 0.00 (0.00%)

REAL-TIME: Last trade at

Extended Hours: $3.79 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

ARRY $3.79 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.85
Previous Close $3.79
Daily Range $3.73 - $3.92
52-Week Range $3.39 - $7.10
Market Cap $475.5M
P/E Ratio -6.30
Dividend (Yield) $0.00 (0.0%)
Volume 1,510,027
Average Daily Volume 1,689,911
Current FY EPS -$0.69

Sector

Healthcare

Industry

Drugs

Array BioPharma (ARRY) Description

A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. Website: http://www.arraybiopharma.com/

News & Commentary Rss Feed

Array BioPharma: A Biotech With Many Shots On Goal

ARRY Crosses Above Key Moving Average Level

Morning Gainers for Mar. 3, 2014: DNDN, PERI, RVNC, ARRY, OMEX, NIHD

Oncothyreon and Array BioPharma Announce Initiation of Phase 1b Trial of ONT-380 in Combination with

Oncothyreon and Array BioPharma Announce Initiation of Phase 1b Trial of ONT-380 in Combination with TDM-1 in Patients with Metastatic HER2+ Breast Cancer

Eight Biotech Stocks Trading Near $5 With Huge Upside Potential

Array BioPharma's CEO Discusses F2Q14 Results - Earnings Call Transcript

Why Array Biopharma Inc. Shares (Briefly) Popped

Is this meaningful? Or just another movement?

Zacks #1 Rank Additions for Tuesday - Tale of the Tape

Array BioPharma's CEO Presents at JPMorgan Healthcare Conference (Transcript)

Oncothyreon Offers Income To Those Accepting Risk

See More ARRY News...

ARRY's Top Competitors

ARRY $3.79 (0.00%)
Current stock: ARRY
AMGN $115.46 (0.00%)
Current stock: AMGN
GILD $70.00 (0.00%)
Current stock: GILD
BIIB $290.54 (0.00%)
Current stock: BIIB